A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The BBC reports that shares of a Chinese semiconductor company surged 470% in a single trading session today, driven entirely by investor speculation rather than any product announcement. The company has not announced any major AI accelerator breakthrough — investors simply bet the firm could capitalize on surging domestic demand for AI chips.
That demand exists for a concrete reason: ongoing U.S. export controls have restricted Chinese access to leading-edge chips from Nvidia, creating an urgent and largely unmet need for domestic alternatives. The chipmaker has become a vessel for that bet, regardless of its actual readiness to deliver.
The 470% move is extreme even by speculative standards, but the underlying dynamic it reflects is real. Capital and attention are flowing aggressively toward anyone who can credibly claim a seat at the AI chip stack — and in China right now, the bar for credible appears to be very low.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division